Chambers Review
Provided by Chambers
Chambers Asia & Pacific
Life Sciences - Japan
Individual Editorial
Yo Uraoka is well placed to handle life science transactions as well as regulatory and litigation work in the sector.
Yo Uraoka
Asia-Pacific Guide 2025
Band 2 : Life Sciences
Email address
[email protected]Contact number
+81 3 5220 1803Share profile
Lawyers profile
Asia-Pacific 2025
Lawyers profile | Asia-Pacific 2025: Life Sciences
Yo Uraoka
Ranked in 1 Practice Areas
Band 2
About
Provided by Yo Uraoka
Asia-Pacific
Practice Areas
Life Sciences, Mergers and Acquisitions, Disputes/Dispute Resolution
Career
Joined Mori Hamada & Matsumoto in 2001, becoming Partner in 2011.
Professional Memberships
Admitted in Japan, 2001; New York, 2009.
Publications
"Getting the Deal Through - Healthcare Enforcement & Litigation 2023 - Japan Chapter", Law Business Research Ltd., 2022. "Q&A: Digital Health and Law [2nd ed.]", Shojihomu Co., Ltd., 2022. "Getting the Deal Through - Healthcare M&A 2021 - Japan Chapter", Law Business Research Ltd., 2021. "Development and Expansion of HealthTech and Corporate Legal Affairs", Dai-ichi Hoki Co. Ltd., 2020. and many others.
Personal
Graduated from the University of Tokyo (LLB 1999); University of Southern California, Law School (LL.M., 2008).
Strengths
Provided by Chambers
Slide 1 of 1
In addition to providing accurate advice on matters specific to life sciences companies, he offers precise guidance on due diligence and M&A. Moreover, his accuracy is exceptionally high.
Yo Uraoka has a wide range of knowledge and connections, so he is the first person I go to when I have any issues.
In addition to providing accurate advice on matters specific to life sciences companies, he offers precise guidance on due diligence and M&A. Moreover, his accuracy is exceptionally high.
Yo Uraoka has a wide range of knowledge and connections, so he is the first person I go to when I have any issues.
Discover other Lawyers at
Mori Hamada & Matsumoto
Provided by Chambers
Filter by
Band
Japan
Banking & Finance: Domestic
Capital Markets: Domestic
Capital Markets: Domestic: J-REITs
Capital Markets: Domestic: Securitisation & Derivatives
Competition/Antitrust
Corporate/M&A: Domestic
20 of 66 results